Ulcerative colitis
Conditions
Interventions
Controlled group:Take mesalazine 1g Qid in active stage. Sustain the treatment for another week after the symptoms relieve. Then take 0.5g Tid and adjust the dosage according to the condition. The tre
Experimental group:Take the intestine-clearing and dissipating dampness formula 2 times a day in the 1st stage. Enema is given once a day for 12 days. Take health-supporting and intestine-clearing for
Sponsors
The Affiliated Hospital of Nanjing University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. In accordance with the diagnosis criteria of ulcerative colitis in Western medicine and: (1) clinical type: first onset and chronic recurrence; (2) severity: mild or moderate; (3) phase: active stage; 2. TCM syndrome differentiation: internal accumulation of damp-heat; 3. Aged between 18 and 65 years old, regardless of sex; 4. Informed consents and willing to participant; the obtaining of informed consent document accords with ethics principles.
Exclusion criteria
Exclusion criteria: 1. Disease type: acute fulminant, persistently chronic; severity: severe; 2. Patients with infectious colitis such as bacillary dysentery, amebic dysentery, chronic schistosomiasis, intestinal tuberculosis, and crohn's disease, ischemic enteritis, radiation enteritis; 3. Patients with severe complications: local stenosis, intestinal obstruction, intestinal perforation, toxic dilation of the colon, massive hemorrhage, colon cancer and rectal cancer; 4. Pregnant or breast-feeding females; 5. Patients with severe primary heart, liver, lung, kidney, hematological diseases or diseases that may influence the survival such as tumor, AIDS, asthma, renal calculi, abnormal renal function; urine protein > +, urinary red cell under microscope.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cure rate and ineffective rate;Relapse rate;Remission rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| quality of life;Safety; | — |
Countries
China
Contacts
Public ContactHong Shen
Outcome results
None listed